Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

AI assesses long-term mortality with single x-ray

Researchers have developed a convolutional neural network (CNN) that predicts long-term mortality from a single chest x-ray, according to new findings published in JAMA Network Open

Thumbnail

Breast density reporting bills don’t affect screening ultrasound utilization

State-level breast density reporting legislation is not associated with any significant changes in ultrasound utilization, according to new findings published in the Journal of the American College of Radiology.

Thumbnail

Have state-level breast density reporting laws impacted screening ultrasound rates?

After looking at more than 12,500 preventative office visits included in the National Ambulatory Medical Care Survey, researchers reported that the rate of screening breast ultrasound ordering by physicians has remained low.

Thumbnail

SNMMI, MITA host briefing to discuss expanding access to radiopharmaceuticals

Industry leaders, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA), hosted a Capitol Hill Briefing July 17, to discuss a bipartisan bill that would expand patient access to diagnostic radiopharmaceuticals.

Thumbnail

LI-RADS 2018 beats version 2017 for diagnosing small HCCs

The updated LR-5 criteria for Liver Imaging Reporting and Data System (LI-RADS) version 2018 can improve sensitivity for diagnosing small hepatocellular carcinomas (HCC) compared to LI-RADS 2017.

Thumbnail

NorthStar wraps up construction of new Mo-99 facility

NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, Wisconsin, the company announced on July 16.

Thumbnail

Cardiac MRI contrast agent receives FDA approval

The FDA has approved Bayer’s gadobutrol (Gadavist) injection for use in cardiac MRI, making it the first contrast agent approved for the imaging technique, according to a statement from Bayer.

Thumbnail

Bayer’s Gadavist injection cleared by FDA for cardiac MR in adults

Bayer announced Monday, July 15, that its Gadavist (gadobutrol) injection has been approved by the FDA for cardiac MR imaging to assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease (CAD).